Open AccessProtection of Mouse Brain from Aluminum‐induced Damage by Caffeic Acid
Author(s) -
Yang JunQing,
Zhou QiXin,
Liu BeiZhong,
He BaiCheng
Publication year - 2008
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/j.1527-3458.2007.00031.x
Subject(s) - caffeic acid , caffeic acid phenethyl ester , malondialdehyde , neuroprotection , neurotoxicity , microinjection , chemistry , pharmacology , biochemistry , lipid peroxidation , oxidative stress , antioxidant , medicine , endocrinology , toxicity
The natural product caffeic acid is a specific inhibitor of 5‐lipoxygenase (5‐LOX); it also possesses antioxidant and antiinflammatory properties. The current study was designed to determine whether the neuroprotective properties of caffeic acid are due to inhibition of 5‐LOX. Cerebral damage was induced in mice by intracerebroventricular microinjection of aluminum (5.0 μg aluminum in 2.0 μL, once a day, for 5 days). Caffeic acid was administered intragastrically at 30 min prior to aluminum and repeated daily for an additional 10 days. The brain injury was determined by observation of behavioral changes in mice, as well as by measuring biochemical and pathological changes in the cerebral tissue. The levels of 5‐LOX proteins and 5‐LOX mRNA expression were measured in brain tissue. Aluminum impaired learning and memory in mice produced neuronal death in hippocampi, elevated brain malondialdehyde levels, increased protein expression of amyloid precursor protein (APP), amyloid beta, and 5‐LOX. It also increased 5‐LOX mRNA expression and decreased choline acetyl transferase (ChAT) protein expression in the brain tissue of mice. Caffeic acid prevented brain damage as well as behavioral and biochemical changes caused by aluminum overload. The results of this study suggest that overexpression of 5‐LOX accompanies the cerebral injury induced by aluminum overload in mice, and that selective inhibitors of 5‐LOX may have potential value in the treatment of aluminum neurotoxicity and conceivably of diseases associated with neuronal injury.